Given that proteomics analysis clearly indicated the strong connection between metabolic proteins and SETD2 deletion, we further performed GSEA analysis on proteomics dataset to identify the alteration of KEGG metabolic pathways during PKD-ccRCC transition (Fig. 4a). The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.